SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737287-20-000047
Filing Date
2020-08-05
Accepted
2020-08-05 07:48:31
Documents
65
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q allo-20200630.htm   iXBRL 10-Q 2007383
2 EX-10.1 allo-20200630xexx101.htm EX-10.1 172746
3 EX-31.1 allo-20200630xex311.htm EX-31.1 11438
4 EX-31.2 allo-20200630xex312.htm EX-31.2 11460
5 EX-32.1 allo-20200630xex321.htm EX-32.1 9694
  Complete submission text file 0001737287-20-000047.txt   7609010

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allo-20200630.xsd EX-101.SCH 42583
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allo-20200630_cal.xml EX-101.CAL 64640
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allo-20200630_def.xml EX-101.DEF 261052
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allo-20200630_lab.xml EX-101.LAB 561249
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allo-20200630_pre.xml EX-101.PRE 359834
11 EXTRACTED XBRL INSTANCE DOCUMENT allo-20200630_htm.xml XML 1273823
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38693 | Film No.: 201075672
SIC: 2836 Biological Products, (No Diagnostic Substances)